<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.

Neuro Therapies

What’s New in Neuromodulation? News to Know Before NANS 2024

The North American Neuromodulation Society (NANS) is celebrating its 30th anniversary in 2024 and is onc...

Neuro Therapies

BREAKING NEWS - Nevro Acquires VYRSA Technologies

Nevro* (NVRO) announced it acquired VYRSA Technologies*, a privately held company focused on the minimal...

Medtronic: Expanding Access to Neurovascular Interventions

Medtronic Neurovascular President Dan Volz discusses expanding patient access to neurovascular therapies...

Neuro Therapies

SNIS 2023: New Frontiers in Stroke Care: An Interview with J Mocco, MD

SNIS President J Mocco, MD, discusses emerging technologies and new frontiers in neurointervention in an...

Neurovascular

What's New in the Neurovascular Market

SmartTRAK constantly monitors the worldwide MedTech industry, sifting through the noise to present to ou...

Neuromodulation

Fingers Crossed for a Market Recovery: Q123 Neuromodulation Market Recap

Neuromodulation companies are keeping their fingers crossed that the positive growth in Q123 is a sign t...

Neuromodulation

The Future of Interventional Pain Management and Peripheral Nerve Stimulation

SmartTRAK’s survey of interventional pain physicians reveals valuable insights into current and future t...

Neuromodulation

What's New and What's Next at Abbott Neuromodulation

Rebecca Wilkins, DVP R&D Neuromodulation for Abbott, discusses the Eterna SCS, strategies for penetr...

Neuro Therapies

Navigating Choppy Waters: Q422 Neuromodulation Market Recap

While the macro environment is improving, some neuromodulation companies and segments navigated choppy w...

Neuro Therapies

Saluda Medical: Changing the Game in Spinal Cord Stimulation

Saluda Medical President and CEO Jim Schuermann discusses the Company, the Evoke System and changing the...

1 2 3 4 5
...
12